We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+22.02%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$79.1M
AUM Growth
+$12.8M
Cap. Flow
+$3.7M
Cap. Flow %
4.68%
Top 10 Hldgs %
18.75%
Holding
129
New
38
Increased
37
Reduced
19
Closed
35

Sector Composition

Rank Sector Weight
1 Technology 28.61%
2 Healthcare 18.94%
3 Industrials 15.17%
4 Consumer Discretionary 9.24%
5 Materials 5.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BECN
76
DELISTED
Beacon Roofing Supply, Inc.
BECN
$485K 0.61%
11,537
-17,790
-61% -$809K
SPNC
77
DELISTED
Spectranetics Corp
SPNC
$485K 0.61%
19,330
-9,350
-33% -$218K
DY icon
78
Dycom Industries
DY
$12B
$463K 0.59%
5,667
-12,100
-68% -$1.07M
PEN icon
79
Penumbra
PEN
$12.7B
$441K 0.56%
5,805
+2,300
+66% +$159K
ITRI icon
80
Itron
ITRI
$4.36B
$440K 0.56%
+7,890
New +$378K
ARIA
81
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$418K 0.53%
30,545
-26,470
-46% -$266K
FN icon
82
Fabrinet
FN
$15.6B
$409K 0.52%
9,170
-18,081
-66% -$718K
OMCL icon
83
Omnicell
OMCL
$1.61B
$407K 0.51%
10,630
-11,610
-52% -$433K
ORBC
84
DELISTED
ORBCOMM, Inc.
ORBC
$386K 0.49%
37,630
+1,625
+5% +$16.6K
DOC
85
DELISTED
PHYSICIANS REALTY TRUST
DOC
$384K 0.49%
17,820
-14,460
-45% -$306K
RGEN icon
86
Repligen
RGEN
$7.96B
$376K 0.48%
+12,445
New +$376K
OCLR
87
DELISTED
Oclaro Inc.
OCLR
$373K 0.47%
+43,665
New +$304K
BETR
88
DELISTED
Amplify Snack Brands, Inc.
BETR
$368K 0.47%
+22,745
New +$356K
SRPT icon
89
Sarepta Therapeutics
SRPT
$1.57B
$332K 0.42%
+5,405
New +$163K
ALRM icon
90
Alarm.com
ALRM
$2.71B
$318K 0.4%
+11,005
New +$307K
SUPN icon
91
Supernus Pharmaceuticals
SUPN
$2.59B
$244K 0.31%
9,865
-27,305
-73% -$618K
AMN icon
92
AMN Healthcare
AMN
$1.3B
$238K 0.3%
7,481
-28,415
-79% -$1.08M
CLVS
93
DELISTED
Clovis Oncology, Inc.
CLVS
$235K 0.3%
+6,505
New +$140K
NKTR icon
94
Nektar Therapeutics
NKTR
$2.39B
$216K 0.27%
+838
New +$216K
ACAD icon
95
Acadia Pharmaceuticals
ACAD
$4.43B
-12,355
Closed -$401K
AMED
96
DELISTED
Amedisys
AMED
-12,745
Closed -$643K
ASRT
97
DELISTED
Assertio
ASRT
-219
Closed -$257K
BYD icon
98
Boyd Gaming
BYD
$6.18B
-17,709
Closed -$326K
FANG icon
99
Diamondback Energy
FANG
$57.1B
-8,000
Closed -$730K
FIVE icon
100
Five Below
FIVE
$12B
-16,265
Closed -$755K

Similar funds

Lisanti Capital Growth's Q3 2016 Portfolio in Review

As of Q3 2016, Lisanti Capital Growth held 129 positions worth $79.1M, up 19% from $66.3M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Lisanti Capital Growth deployed $3.7M of net new capital in Q3 2016, opening 38 new positions and adding to 37 existing holdings. Its largest new stake was ZELTIQ Aesthetics, Inc.: 35,830 shares worth $1.41M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was AMN Healthcare, an estimated $1.08M trimmed.

  • Lisanti Capital Growth's largest Q3 2016 buy was ZELTIQ Aesthetics, Inc.: 35,830 shares worth $1.41M.
  • Lisanti Capital Growth added most to PARSLEY ENERGY INC in Q3 2016, an estimated $681K increase.
  • Lisanti Capital Growth's biggest Q3 2016 reduction was AMN Healthcare, cutting an estimated $1.08M.
  • Lisanti Capital Growth fully exited Tile Shop Holdings in Q3 2016, selling an estimated $1.29M.
  • Lisanti Capital Growth's ten largest holdings make up 19% of its $79.1M portfolio in Q3 2016.
  • Lisanti Capital Growth opened 38 new positions and closed 35 in Q3 2016.
  • Lisanti Capital Growth's portfolio value rose 19% quarter-over-quarter to $79.1M.

Based on Lisanti Capital Growth's 13F filing for Q3 2016, filed 24 Oct 2016.